SAN DIEGO, April 23 /PRNewswire/ --
Accumetrics, Inc. announces today an exclusive distribution agreement with ELITech UK Limited for distribution of the VerifyNow System in the United Kingdom. The distribution agreement marks the beginning of several new distribution channels for the Company as it expands its reach both in scope and geography. ELITech UK will concentrate its efforts on reaching customers in surgery suites and catheterization labs within UK hospitals and other medical centers.
We are very pleased to have ELITech UK become our exclusive UK distributor. Their demonstrated expertise in this market and knowledge of our customer base in the UK will help expedite physician access to our products, said Timothy I. Still, President and CEO of the Company. This partnership marks the beginning of our distribution channel expansion outside the U.S. and demonstrates our focus on rapidly growing our global presence.
Distribution of the VerifyNow System is extremely complementary to our current portfolio of products, and we are delighted to add them among our customers, said Tim Watson, Managing Director of ELITech UK. The VerifyNow System is an excellent fit with our expertise within the interventional cardiology market, and we look forward to a long and prosperous partnership with Accumetrics.
About Accumetrics (www.accumetrics.com)
Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.
Accumetrics' VerifyNow System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, prasugrel, Plavix(R), ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.
The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc., ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of Sanofi-Aventis.
About ELITech UK Limited (www.elitechuk.com)
Founded in 2000 ELITech UK Limited is a wholly owned subsidiary of the Pan European marketing and distribution company ELITech Group based in France. The ELITech Group (www.elitechgroup.com) is now a 60 million Euro in vitro diagnostic company with global sales and distribution capabilities in over 100 countries. ELITech offers clinical chemistry, microbiology, immunology and electrophoresis products and operates globally, leveraging products from its own biochemistry and microbiology equipment and reagents manufacturing facilities as well as third party products. In May 2007 ELITech acquired Wescor Inc, Utah USA to broaden its biomedical products platform and to provide a base for business expansion in the USA. In October 2007, ELITech acquired Vital Scientific in the Netherlands to allow the company to offer a complete biochemistry offering.
CONTACT: Jules Abraham Lippert/Heilshorn Associates +1-212-838-3777 jabraham@lhai.com Timothy I. Still President and CEO Accumetrics +1-858-404-8260 press@accumetrics.com
Jules Abraham of Lippert/Heilshorn Associates, +1-212-838-3777, jabraham@lhai.com, for Accumetrics, Inc.; or Timothy I. Still, President and CEO of Accumetrics, +1-858-404-8260, press@accumetrics.com
Comments